Icon

FRUZAQLA - (1MG, 5MG ; Capsule)

FRUQUINTINIB Takeda
1MG, 5MG ; Capsule
Less Than $1000 mn
None None
Less Than 5
None
None None
FRUZAQLA is a kinase inhibitor indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
Yes
FRUZAQLA Patent 1 Patent 2 Patent 3 Patent 4
*** *********
*** ** *********** *********** ********* ** ******** ************-******* ******** *********** *********** ********* *** ***** *** ** ******** ************-******* ******** *********** ***** ** *-((*,*-*******************-*-**)***)-*,*-******************-*-*********** *********** ***** ** *-((*,*-*******************-*-**)***)-*,*-******************-*-***********
  1. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.*,***,*** (*** *, **** ).**** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ***** **, ****
  2. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.*,***,*** (*** *, **** ).**** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ***** **, ****
  3. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.**,***,*** (********* *, **** ).**** **** ********* ** *** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ******** *, ****
  4. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.**,***,*** (********* *, **** ).**** **** ********* ** *** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ******** *, ****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.